MGAT5 and neoplasm: In addition, Mgat5 KO mice exhibited, at the latest timepoint, a significantly lower number of tumor lesions (Figure 2D) with smaller sizes (Figure 2E) than WT mice, which support that a deficiency in Mgat5-mediated branched N-glycans delays CAC progression.